Atsushi Yukimoto

430 total citations
24 papers, 255 citations indexed

About

Atsushi Yukimoto is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Atsushi Yukimoto has authored 24 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 14 papers in Hepatology and 6 papers in Surgery. Recurrent topics in Atsushi Yukimoto's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Atsushi Yukimoto is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Atsushi Yukimoto collaborates with scholars based in Japan. Atsushi Yukimoto's co-authors include Masashi Hirooka, Yoichi Hiasa, Takao Watanabe, Masanori Abe, Osamu Yoshida, Yohei Koizumi, Yoshio Tokumoto, Kouji Joko, Kojiro Michitaka and Yusuke Imai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Mayo Clinic Proceedings.

In The Last Decade

Atsushi Yukimoto

23 papers receiving 251 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Yukimoto Japan 9 177 173 50 31 29 24 255
Virginia Knight Australia 10 210 1.2× 200 1.2× 35 0.7× 42 1.4× 16 0.6× 15 313
Emily Zhang United States 4 210 1.2× 209 1.2× 22 0.4× 41 1.3× 17 0.6× 5 280
Philippe Kolly Switzerland 9 189 1.1× 209 1.2× 33 0.7× 34 1.1× 20 0.7× 10 306
Nancy Kwan Man Hong Kong 4 156 0.9× 125 0.7× 77 1.5× 29 0.9× 20 0.7× 6 201
Nicoletta De Matthaeis Italy 11 154 0.9× 133 0.8× 62 1.2× 16 0.5× 13 0.4× 21 249
Yoshihiko Aoki Japan 9 160 0.9× 155 0.9× 21 0.4× 39 1.3× 19 0.7× 22 285
Cristina Margini Switzerland 6 203 1.1× 220 1.3× 76 1.5× 16 0.5× 38 1.3× 10 338
Yuki Kugiyama Japan 8 366 2.1× 318 1.8× 42 0.8× 40 1.3× 11 0.4× 13 439
Jui‐Ting Hu Taiwan 10 178 1.0× 222 1.3× 33 0.7× 20 0.6× 17 0.6× 24 340
Owen Cain United Kingdom 6 115 0.6× 111 0.6× 103 2.1× 23 0.7× 16 0.6× 15 264

Countries citing papers authored by Atsushi Yukimoto

Since Specialization
Citations

This map shows the geographic impact of Atsushi Yukimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Yukimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Yukimoto more than expected).

Fields of papers citing papers by Atsushi Yukimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Yukimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Yukimoto. The network helps show where Atsushi Yukimoto may publish in the future.

Co-authorship network of co-authors of Atsushi Yukimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Yukimoto. A scholar is included among the top collaborators of Atsushi Yukimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Yukimoto. Atsushi Yukimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nozawa, Akinori, et al.. (2024). Integrated policy of medical expense subsidies and clinical registry for patients with liver cancer and decompensated cirrhosis in Japan. Hepatology Research. 54(8). 745–752. 1 indexed citations
2.
Hirooka, Masashi, Yohei Koizumi, Yoshiko Nakamura, et al.. (2022). Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites. Scientific Reports. 12(1). 8124–8124. 4 indexed citations
3.
Miyake, Teruki, Osamu Yoshida, Bunzo Matsuura, et al.. (2022). Additional Effect of Luseogliflozin on Semaglutide in Nonalcoholic Steatohepatitis Complicated by Type 2 Diabetes Mellitus: An Open-Label, Randomized, Parallel-Group Study. Diabetes Therapy. 13(5). 1083–1096. 8 indexed citations
4.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2021). AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy. BMC Cancer. 21(1). 699–699. 14 indexed citations
5.
Tanaka, Takaaki, Masashi Hirooka, Yohei Koizumi, et al.. (2021). Development of a method for measuring spleen stiffness by transient elastography using a new device and ultrasound-fusion method. PLoS ONE. 16(2). e0246315–e0246315. 12 indexed citations
6.
Yukimoto, Atsushi, Takao Watanabe, Yoshiko Nakamura, et al.. (2021). The long noncoding RNA of RMRP is downregulated by PERK, which induces apoptosis in hepatocellular carcinoma cells. Scientific Reports. 11(1). 7926–7926. 8 indexed citations
7.
Hirooka, Masashi, Takaaki Tanaka, Yohei Koizumi, et al.. (2021). Accurate reflection of hepatic venous pressure gradient by spleen stiffness measurement in patients with low controlled attenuation parameter values. JGH Open. 5(10). 1172–1178. 7 indexed citations
8.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2020). Sex difference in the development of hepatocellular carcinoma after direct‐acting antiviral therapy in patients with HCV infection. Journal of Medical Virology. 92(12). 3507–3515. 6 indexed citations
9.
Hirooka, Masashi, Yohei Koizumi, Takaaki Tanaka, et al.. (2020). Dilatation of lymphatic vessels increases liver stiffness on transient elastography irrespective of fibrosis. Hepatology Research. 51(3). 284–293. 2 indexed citations
10.
Hirooka, Masashi, Yohei Koizumi, Takaaki Tanaka, et al.. (2020). Treatment on the Spleen Prevents the Progression of Secondary Sarcopenia in Patients With Liver Cirrhosis. Hepatology Communications. 4(12). 1812–1823. 6 indexed citations
11.
Miyake, Teruki, Shinya Furukawa, Hidenori Senba, et al.. (2020). Advanced fibrosis of non-alcoholic steatohepatitis affects the significance of lipoprotein(a) as a cardiovascular risk factor. Atherosclerosis. 299. 32–37. 30 indexed citations
12.
Imai, Yusuke, Osamu Yoshida, Takao Watanabe, et al.. (2019). Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation. PLoS ONE. 14(2). e0212589–e0212589. 16 indexed citations
13.
Imai, Yusuke, Masashi Hirooka, Atsushi Yukimoto, et al.. (2019). A case of refractory liver abscess due to hypermucoviscous <i>Klebsiella pneumoniae</i> resolved by hepatectomy. Kanzo. 60(11). 427–432. 2 indexed citations
14.
Kumagi, Teru, Tomoyuki Yokota, Nobuaki Azemoto, et al.. (2019). Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance. Mayo Clinic Proceedings. 94(10). 2004–2010. 6 indexed citations
15.
Koizumi, Yohei, Masashi Hirooka, Takaaki Tanaka, et al.. (2019). Schistosomiasis Diagnosed Using Laparoscopy and Colonoscopy. Internal Medicine. 58(17). 2495–2499. 1 indexed citations
16.
Koizumi, Yohei, Masashi Hirooka, Atsushi Hiraoka, et al.. (2019). Lenvatinib-induced thyroid abnormalities in unresectable hepatocellular carcinoma. Endocrine Journal. 66(9). 787–792. 25 indexed citations
17.
Watanabe, Takao, Yoshio Tokumoto, Kouji Joko, et al.. (2018). Predictors of hepatocellular carcinoma occurrence after direct‐acting antiviral therapy in patients with hepatitis C virus infection. Hepatology Research. 49(2). 136–146. 45 indexed citations
18.
Hirooka, Masashi, Yohei Koizumi, Yusuke Imai, et al.. (2018). Validation trial for efficacy of ultrasonographic measurement method to predict ascitic volume using virtual ultrasonography. Journal of Medical Ultrasonics. 45(4). 555–564. 1 indexed citations
19.
Yukimoto, Atsushi, Masashi Hirooka, Atsushi Hiraoka, et al.. (2018). Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinoma. Japanese Journal of Clinical Oncology. 49(1). 42–47. 22 indexed citations
20.
Hirooka, Masashi, Yohei Koizumi, Teruki Miyake, et al.. (2017). Nonalcoholic fatty liver with a hepatic arterial buffer response strongly associated with future metabolic disease. Hepatology Communications. 1(7). 623–633. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Knight Breakdown of academic impact, for papers by Emily Zhang Breakdown of academic impact, for papers by Philippe Kolly Breakdown of academic impact, for papers by Nancy Kwan Man Breakdown of academic impact, for papers by Nicoletta De Matthaeis Breakdown of academic impact, for papers by Yoshihiko Aoki Breakdown of academic impact, for papers by Cristina Margini Breakdown of academic impact, for papers by Yuki Kugiyama Breakdown of academic impact, for papers by Jui‐Ting Hu Breakdown of academic impact, for papers by Owen Cain
Rankless by CCL
2026